The incidence of large fetomaternal hemorrhage and the kleihauer-betke test

Obstetrics and Gynecology

Volumn 105, Issue 5, 2005, Pages 1039-1044

  Nachum, Zohar ^a   Mader, Rivka ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; ELECTIVE SURGERY; ETHNIC GROUP; FEMALE; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; GYNECOLOGICAL EXAMINATION; HUMAN; INCIDENCE; LABOR COMPLICATION; LOW BIRTH WEIGHT; OLIGOHYDRAMNIOS; PARITY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; UMBILICAL CORD; VAGINAL DELIVERY;

ADULT; CASE-CONTROL STUDIES; CESAREAN SECTION; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FETOMATERNAL TRANSFUSION; FOLLOW-UP STUDIES; GESTATIONAL AGE; HEMATOLOGIC TESTS; HUMANS; INCIDENCE; MATERNAL AGE; NATURAL CHILDBIRTH; ODDS RATIO; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 17644362987     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000157115.05754.3c     Document Type: Article

References (27)

1. Bowman JM. Controversies in Rh prophylaxis: who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol 1985;151:289-94.
2. Stedman CM, Baudin JC, White CA, Cooper ES. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women. Am J Obstet Gynecol 1986;154:1363-9.
3. Ness PM, Baldwin ML, Niebyl JR. Clinical high-risk designation dose not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987;156:154-8.
4. Bowman JM, Pollock JM. Antenatal Rh prophylaxis: 28 week gestation service program. Can Med Assoc J 1978;118:627-30.
5. Pollack W, Ascari WQ, Kochesky RJ, O’Connor RR, Ho TY, Tripodi D. Studies on Rh prophylaxis. I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333-9.
6. Li TC, Bromham DR, Balmer BM. Fetomaternal macrotransfusion in the Yorkshire region. I. Prevalence and obstetric factors. Br J Obstet Gynaecol 1988;95:1144-51.
7. Cohen F, Zuelzer W, Gustafson DC, Evans MM. Mechanisms of isoimmunization. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies. Blood 1964;23:621-46.
8. Kleihauer E, Braun H, Betke K. Demonstration von fetalem hemoglobin in der erythrocyten eines blutausstrichs. Klin Wochenschr 1957;35:637-8.
9. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. Disease and injuries of the fetus and newborn. In: Williams Obstetrics. 21st ed. New York (NY): McGraw-Hill; 2001. p. 1039-91.
10. Farabow WS, Weinstein L, Gusdon JP Jr. Transplacental hemorrhage presenting as severe fetal distress: report of a case. Obstet Gynecol 1970;36:212-4.
11. Fay RA. Feto-maternal haemorrhage as a cause of fetal morbidity and mortality. Br J Obstet Gynaecol 1983;90:443-6.
12. Devi B, Jennison RF, Langley FA. Relationship of transplacental hemorrhage to abnormal pregnancy and delivery. J Obstet Gynaecol Br Commonw 1968;75:659-66.
13. Weatherall DJ, Clegg JB. The Thalassaemia syndromes. 3rd ed. Oxford (UK): Blackwell Scientific; 1981. p. 72-84.
14. Zago MA, Wood WG, Clegg JB, Weatherall DJ, O'Sullivan M, Gunson H. Genetic control of F-cells in human adults. Blood 1979;53:977-86.
15. Boyer SH, Belding TK, Margolet L, Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F-cells) in normal human adults. Science 1975;188:361-3.
16. Wood WG, Stamatoyannopoulos G, Lim G, Nute PE. F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. Blood 1975;46:671-82.
17. Kleihauer E, Betke K. Practical use of the demonstration of cells containing hemoglobin F in fixed blood smears [in German]. Izv Mikrobiol Inst 1960;1:292-5.
18. Bromilow I, Duguid JKM, Walkinshaw S. Lesson of the week: importance of accurate assessment of fetomaternal haemorrhage after late abortions. BMJ 1996;313:1200-1.
19. Popat N, Wood WG, Weatherall DJ, Turnbull AC. Pattern of maternal F-cell production during pregnancy. Lancet 1977;2:377-9.
20. Seiverd CE. Hematology for medical technologists. 4th ed. Philadelphia (PA): Lea & Febiger; 1973. p. 511-2.
21. Mollison PL. Quantitation of transplacental haemorrhage. BMJ 1972;3:31-4.
22. Widmann FK. Technical manual of the American Association of Blood Banks. 8th ed. Philadelphia (PA): J.B. Lippincott; 1981.
23. Duguid JK, Bromilow I. Value of Kleihauer testing after administration of anti-D immunoglobulin. BMJ 1994;309:240.
24. Bromilow IM, Duguid JK. Measurement of feto-maternal haemorrhage: a comparative study of three Kleihauer techniques and two flow cytometry methods. Clin Lab Haematol 1997;19:137-42.
25. Fong EA, Davies JI, Grey DE, Reid PJ, Erber WN. Detection of massive transplacental haemorrhage by flow cytometry. Clin Lab Haematol 2000;22:325-7.
26. Johnson PR, Tait RC, Austin EB, Shwe KH, Lee D. Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol 1995;48:1005-8.
27. Lafferty JD, Raby A, Crawford L, Linkins LA, Richardson H, Crowther M. Fetal-maternal hemorrhage detection in Ontario. Am J Clin Pathol 2003;119:72-7.